Policy | November 11, 2025
Trump clinches historic deal as Lilly, Novo slash U.S. weight-loss drug prices
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Relmada expects to initiate its Phase 3 program in the first half of 2026
Poviztra is a second brand of Wegovy
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Cupid has been allocated approximately 23.4 million units of female condoms per year
Subscribe To Our Newsletter & Stay Updated
